Zostavax is a vaccine that prevents herpes zoster (shingles or zoster) caused by reactivation of varicella-zoster (chickenpox) virus (VZV). In this drug monograph, Dr. Ome Ogbru answers these questions: how does Zostavax work, what is it used for, how is it administered, what are the side effects, and what are the drug interactions.
Tags: Chickenpox, Vaccine
Most Recently Shared on December 21, 2011 at 1:03 am By:
Ome Ogbru, PharmD
Zostavax is a vaccine that prevents herpes zoster (shingles or zoster) caused by reactivation of varicella-zoster (chickenpox) virus (VZV). In this drug monograph, Dr. Ome Ogbru answers these questions: how does Zostavax work, what is it used for, how is it administered, what are the side effects, and what are the drug interactions.
View Related Resources
aidsmeds.com — “Two doses of Zostavax, a vaccine against shingles (herpes zoster), administered six weeks apart is \'generally safe\' for people living with HIV with CD4 counts of 200 or higher and undetectable viral loads, according to study results shared Wednesday, March 7, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI).” View full resource at aidsmeds.com
Most Recently Shared on March 13, 2012 at 1:01 pm By:
drugs.com — “Zostavax (zoster vaccine live) is used for prevention of herpes zoster. Information from Drugs.com includes Zostavax side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 27, 2011 at 9:00 pm By:
drugs.com — “Zostavax (zoster vaccine live) is used for prevention of herpes zoster. Information from Drugs.com includes Zostavax side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 26, 2011 at 7:13 pm By:
healthnews.com — “The U.S. Food and Drug Administration (FDA) has now approved use of the varicella-zoster vaccine, Zostavax, among patients ages 50 to 59 for the prevention of herpes zoster, more commonly known as shingles. Until now, use of the vaccine had only been sanctioned for use in people aged 60 or older.” View full resource at healthnews.com
Most Recently Shared on March 25, 2011 at 4:15 pm By:
empr.com — “Merck announced that Zostavax (varicella zoster vaccine, live, attenuated) has gained an expanded indication for the prevention of herpes zoster (shingles) in individuals 50--59 years of age.” View full resource at empr.com
Most Recently Shared on March 25, 2011 at 2:59 pm By:
medicinenet.com — “The shingles vaccine (Zostavax) is given to people over 60 years of age to prevent shingles. Read about side effects, contraindications, dosage and adverse reactions.” View full resource at medicinenet.com
Most Recently Shared on November 10, 2010 at 5:51 pm By:
